Semaglutide vs Tirzepatide: Which Is Right for You?

Semaglutide and tirzepatide are two medications commonly used in medically guided weight-management programs. They work in related ways, but they are not identical and the right choice depends on your medical history, treatment goals, and how your body responds.

At Forma Wellness, eligible patients may be considered for Forma Signature (semaglutide-based injectable), Forma Core (semaglutide-based tablet), or Forma Complete (tirzepatide-based). A licensed healthcare provider determines whether treatment is medically appropriate, and which option may be the better fit for you.

What is the difference between semaglutide vs tirzepatide?

Semaglutide targets one hormone pathway (GLP-1), while tirzepatide targets two (GLP-1 and GIP) that's the main biological difference between them.

GLP-1 is a naturally occurring hormone involved in appetite, digestion, and blood-sugar regulation. Medications that activate this pathway may help patients feel satisfied with smaller portions and stay full longer.

Tirzepatide also activates the GIP receptor, a second hormone involved in metabolic signaling and how the body responds to food. Because it works through two pathways instead of one, some providers may consider it when a broader metabolic approach is appropriate.

Both medications are typically administered on a recurring schedule and introduced gradually, with dose increases guided by the prescribing provider. Increasing a dose too quickly can raise the likelihood of side effects.

	Semaglutide	Tirzepatide
Mechanism	GLP-1 receptor agonist (single pathway)	GLP-1 + GIP receptor agonist (dual pathway)
Forma Wellness Program	Forma Signature (injectable) or Forma Core (tablet)	Forma Complete
Average clinical trial result	Meaningful weight reduction in FDA-approved clinical trials	Greater average weight reduction than semaglutide in a 72-week head-to-head trial*
Dosing	Gradual, recurring schedule set by provider	Gradual, recurring schedule set by provider

*Based on a direct comparative clinical trial in adults with obesity without diabetes. Individual results vary and cannot be predicted from study averages.

Program names refer to Forma Wellness services, not separate drug names or FDA-approved medications.

Which medication leads to more weight loss?

In a 72-week head-to-head clinical trial of adults with obesity, tirzepatide produced greater average weight reduction than semaglutide but that trial average can't predict any one person's individual result.

Results vary depending on factors such as:

• Starting weight and health history

• Medication dose and treatment duration

• Individual biological response

• Nutrition and activity patterns

• Treatment consistency

• Side-effect tolerance

• Other medications or medical conditions
  

More weight loss on paper isn't automatically a better treatment experience. A medication can be effective in a study but still be unsuitable for a specific patient because of side effects, contraindications, cost, or other health considerations. The goal is finding a medically appropriate, individualized treatment plan you can use safely and consistently not simply picking the option with the highest study average.

Are side effects different between the two?

Semaglutide and tirzepatide share many of the same potential side effects, mostly gastrointestinal nausea, diarrhea, constipation, vomiting, abdominal discomfort, and reduced appetite are the most commonly reported.

Symptoms tend to be more noticeable when starting treatment or after a dose increase. Providers typically use gradual dose escalation to improve tolerability, though individual responses still vary.

Before starting treatment, patients should share their complete medical history, including any history of gastrointestinal problems, gallbladder disease, pancreatitis, kidney concerns, diabetes, diabetic eye disease, or personal/family history relevant to thyroid cancer or multiple endocrine neoplasia syndrome type 2.

One additional consideration with tirzepatide: because it delays stomach emptying, it can affect how well the body absorbs some oral medications, including oral hormonal contraceptives your provider will review this with you if relevant.

Seek urgent medical care for severe or persistent abdominal pain, signs of a serious allergic reaction, repeated vomiting, or severe dehydration.

How do I know which one is right for me?

The right medication is determined by a licensed healthcare provider after reviewing your health history, goals, current medications, and any risk factors not by comparison charts or what worked for someone else. See how the consultation process works before you begin.

Semaglutide may be considered for patients seeking an established GLP-1-based approach, available through Forma Signature or Forma Core. Tirzepatide may be considered when a provider believes dual GLP-1/GIP activity is appropriate, available through Forma Complete.

During your consultation, your provider may review:

• Your current weight and weight-related health concerns

• Previous weight-management efforts and results

• Whether you've used a GLP-1-based medication before

• Existing medical conditions and current prescriptions

• Pregnancy or breastfeeding status

• Potential contraindications

• Your ability to follow the treatment and monitoring plan
  

You shouldn't choose a medication solely because it worked for a friend, family member, or influencer. Medical weight management should be individualized, with a prescription coming only from a licensed provider who can evaluate whether treatment is appropriate for you.

Frequently Asked Questions

Is tirzepatide stronger than semaglutide?

Tirzepatide activates both GLP-1 and GIP receptors, while semaglutide activates GLP-1 alone. Clinical studies of FDA-approved products found greater average weight reduction with tirzepatide in certain populations but that doesn't make it automatically the right choice for every patient. A provider determines the appropriate treatment based on your individual health profile.

Can I switch from semaglutide to tirzepatide?

A provider may determine a switch is appropriate, but patients should never stop, start, combine, or change medications without medical guidance. Your provider will consider your current dose, response, side effects, and medical history, and may set a new dose-escalation schedule even if you've used a similar medication before.

Do both require a prescription?

Yes semaglutide and tirzepatide are prescription medications and should only be used under the supervision of a licensed healthcare provider. Buying medication from an unverified seller or using someone else's prescription creates serious safety risks.

Choosing Your Next Step

There's no single medication that's right for everyone. Semaglutide and tirzepatide are different treatment pathways, and both require an individualized medical assessment.

Forma Wellness connects eligible patients with licensed providers who review their health history and determine whether a medical weight-management program and which pathway is appropriate. Your provider, not an online quiz or comparison chart, makes the final decision. See answers to more common questions.

Ready to explore your options?

See if you qualify and start your consultation.

Medical disclaimer: This content is for general educational purposes only and is not medical advice. Eligibility, medication selection, dosing, and treatment decisions are determined by a licensed healthcare provider. Compounded medications are not FDA-approved, and the FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed. Compounded medications may be prescribed only when clinically appropriate and legally available. Individual results vary. No specific outcome is guaranteed.